Abiopharma

🔍 REED JOHN C (Director)

Company: MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Report Date: 2026-08-15

Detailed Transactions and Holdings:

• Acquired 647 shares of Common Stock (Direct)
  Date: 2026-08-15 | Code: A | equity_swap_involved: 0 | shares_owned_after: 647.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 1,078 shares of Stock Option (Right to Buy) at $507.56 per share (Derivative)
  Date: 2026-08-15 | Code: A | Expires: 2036-08-15 | equity_swap_involved: 0 | shares_owned_after: 1,078.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Represents a grant of restricted stock units which vest as to 50% of the shares on each of August 15, 2027 and August 15, 2028, provided the Reporting Person continues in service with the Issuer on each such date.
• F2: The option vests as to 50% of the shares on the first anniversary of the date of grant (August 15, 2027), and, thereafter, 12.5% of the shares shall vest on the last day of each successive three-month period for four successive three-month periods, provided the Reporting Person continues in service with the Issuer on each such date.